Scholar Rock Holding (SRRK) Interest & Investment Income (2024 - 2026)
Scholar Rock Holding's quarterly Interest & Investment Income came in at $2.9 million in Q1 2026, down 30.6% year-on-year from $4.2 million in Q1 2025, and down 16.76% quarter-over-quarter from $3.5 million in Q4 2025.
Scholar Rock Holding has reported Interest & Investment Income for 3 years, with the latest figure at $2.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 30.6% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.6 million (down 7.26% YoY), and the FY2025 full-year result was $13.9 million, up 9.6% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.9 million, down from $3.5 million in the prior quarter.
- The five-year high for Interest & Investment Income was $4.6 million in Q4 2024, with the low at $2.1 million in Q3 2024.
- Average Interest & Investment Income over 3 years is $3.3 million, with a median of $3.3 million recorded in 2024.
- Year-over-year, Interest & Investment Income jumped 31.2% in 2025 and tumbled 30.6% in 2026.
- Tracing SRRK's Interest & Investment Income over 3 years: stood at $4.6 million in 2024, then slipped by 22.69% to $3.5 million in 2025, then decreased by 16.76% to $2.9 million in 2026.
- The last three Interest & Investment Income figures came in at $2.9 million (Q1 2026), $3.5 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.94 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.72 Mn |
| Mar 31, 2024 | 3.32 Mn |